Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies

开发用于评估中和抗体的假型VSV-SARS-CoV-2刺突蛋白变体

阅读:6
作者:Atike Nur Cimen ,Gizem Celebi Torabfam ,Yesim Tuyji Tok ,Ebru Yucebag ,Nese Arslan ,Devrim Saribal ,Gulen Esken ,Ozlem Dogan ,Mert Ahmet Kuskucu ,Bilgul Mete ,Gokhan Aygun ,Fehmi Tabak ,Fusun Can ,Onder Ergonul ,Kenan Midilli ,Ozlem Kutlu ,Sibel Cetinel

Abstract

Aim: Serological studies with pseudotyped viruses offer a safer alternative to live SARS-CoV-2 in evaluating neutralizing antibodies, enabling research in standard labs.Methods: The SARS-CoV-2 Spike pseudotyped vesicular stomatitis virus (VSV) pseudoviruses were generated using Spike of Wuhan strain and two variants (B.1.1.7, B.1.351) and utilized to evaluate the serum neutralizing activity of human plasma samples of vaccinated (n = 13) and healthy people (n = 2) compared with a plaque assay with authentic virus.Results: Neutralizing titer of convalescent plasma resulted with a good correlation (R2 = 0.7).Conclusion: We evaluated a safe and reliable pseudotyped virus system that effectively mimics authentic virus and correlates well with traditional assays. The developed system allows easier testing of variants and has the potential to improve vaccine development. Keywords: Spike variants; VSV-SARS-CoV-2; convalescent plasma; neutralization assay; pseudovirus assay.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。